Cite Filings / AMLX / 0000899243-23-001580

Feed Companies Filings Check

Sign in

5

Annual Insider Trading Report

Amylyx Pharmaceuticals, Inc. Filed 2023-01-11 Acc 0000899243-23-001580

Documents 1

5 Annual Insider Trading Report , xslF345X03/doc5.xml

Around this filing

2023-02-14 5 Annual Insider Trading Report
2023-01-11 5 Annual Insider Trading Report
2023-01-10 4 Chief Medical Officer sold 2,034 shares at an average $36.30 ($73,831)
2023-01-10 4 Co-Chief Executive Officer sold 5,968 shares at an average $36.30 ($216,629)
2023-01-10 4 Chief Financial Officer sold 2,658 shares at an average $36.30 ($96,481)
2023-01-10 4 Chief Commercial Officer sold 2,403 shares at an average $36.30 ($87,225)
2023-01-10 4 Co-Chief Executive Officer sold 5,968 shares at an average $36.30 ($216,629)

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslF345X03/doc5.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…